| Mr Gregory J Rivenbark, CAA | |
|
7757 Auburn Rd Ste 15, Painesville, OH 44077-9604 | |
| (440) 350-0832 | |
| Not Available |
| Full Name | Mr Gregory J Rivenbark |
|---|---|
| Gender | Male |
| Speciality | Anesthesiologist Assistant |
| Location | 7757 Auburn Rd Ste 15, Painesville, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164089306 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 67000350 (Ohio) | Primary |
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
Brighton Hospital, the second-oldest alcohol and drug treatment provider in North America, has signed a letter of intent to begin a long-term management contract with a Saudi Arabian company to build a 291,000 square-foot, 250 bed addiction treatment facility in Riyadh, to serve the entire Islamic Mideast.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of Americans, appear in the current issue of Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.
Research published today in The American Journal of Managed Care demonstrates that analysis of patient records using state-of-the-art data analytics can predict future risk of metabolic syndrome.
› Verified 4 days ago
| Entity Name | Anesthesia Associates Pll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801823182 PECOS PAC ID: 5395648679 Enrollment ID: O20040202000866 |
News Archive
Brighton Hospital, the second-oldest alcohol and drug treatment provider in North America, has signed a letter of intent to begin a long-term management contract with a Saudi Arabian company to build a 291,000 square-foot, 250 bed addiction treatment facility in Riyadh, to serve the entire Islamic Mideast.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of Americans, appear in the current issue of Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.
Research published today in The American Journal of Managed Care demonstrates that analysis of patient records using state-of-the-art data analytics can predict future risk of metabolic syndrome.
› Verified 4 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
Brighton Hospital, the second-oldest alcohol and drug treatment provider in North America, has signed a letter of intent to begin a long-term management contract with a Saudi Arabian company to build a 291,000 square-foot, 250 bed addiction treatment facility in Riyadh, to serve the entire Islamic Mideast.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of Americans, appear in the current issue of Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.
Research published today in The American Journal of Managed Care demonstrates that analysis of patient records using state-of-the-art data analytics can predict future risk of metabolic syndrome.
› Verified 4 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
Brighton Hospital, the second-oldest alcohol and drug treatment provider in North America, has signed a letter of intent to begin a long-term management contract with a Saudi Arabian company to build a 291,000 square-foot, 250 bed addiction treatment facility in Riyadh, to serve the entire Islamic Mideast.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of Americans, appear in the current issue of Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.
Research published today in The American Journal of Managed Care demonstrates that analysis of patient records using state-of-the-art data analytics can predict future risk of metabolic syndrome.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gregory J Rivenbark, CAA 7757 Auburn Rd Ste 15, Painesville, OH 44077-9604 Ph: (440) 350-0832 | Mr Gregory J Rivenbark, CAA 7757 Auburn Rd Ste 15, Painesville, OH 44077-9604 Ph: (440) 350-0832 |
News Archive
Brighton Hospital, the second-oldest alcohol and drug treatment provider in North America, has signed a letter of intent to begin a long-term management contract with a Saudi Arabian company to build a 291,000 square-foot, 250 bed addiction treatment facility in Riyadh, to serve the entire Islamic Mideast.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of Americans, appear in the current issue of Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.
Research published today in The American Journal of Managed Care demonstrates that analysis of patient records using state-of-the-art data analytics can predict future risk of metabolic syndrome.
› Verified 4 days ago
Thomas Bender, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-354-7420 | |
Matthew Ciotti, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-354-7420 | |
Marcus Steven Bartels, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 7590 Auburn Rd, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-579-0191 |